BindingDB logo
myBDB logout

BDBM50356592 CHEMBL1910116

SMILES: CNC(=O)CN1Cc2c(nc(C)c(CN)c2-c2ccc(Cl)cc2Cl)C1=O

InChI Key: InChIKey=LUDLSGUXLBEWMJ-UHFFFAOYSA-N

Data: 3 KI  1 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50356592   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Dipeptidyl peptidase 4


(Homo sapiens (Human))
BDBM50356592
PNG
(CHEMBL1910116)
Show SMILES CNC(=O)CN1Cc2c(nc(C)c(CN)c2-c2ccc(Cl)cc2Cl)C1=O |(7.18,-19.79,;7.95,-21.12,;9.49,-21.12,;10.26,-22.45,;10.26,-19.78,;11.79,-19.78,;12.69,-21.03,;14.16,-20.55,;14.16,-19.01,;15.49,-18.24,;16.82,-19,;18.16,-18.23,;16.83,-20.55,;18.17,-21.32,;19.5,-20.55,;15.49,-21.32,;15.5,-22.86,;14.16,-23.63,;14.16,-25.17,;15.49,-25.94,;15.49,-27.48,;16.83,-25.16,;16.83,-23.62,;18.16,-22.85,;12.7,-18.54,;12.22,-17.07,)|
Show InChI InChI=1S/C18H18Cl2N4O2/c1-9-12(6-21)16(11-4-3-10(19)5-14(11)20)13-7-24(8-15(25)22-2)18(26)17(13)23-9/h3-5H,6-8,21H2,1-2H3,(H,22,25)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
0.370n/an/an/an/an/an/an/an/a



Bristol-Myers Squibb Research and Development

Curated by ChEMBL


Assay Description
Inhibition of DPP4


Bioorg Med Chem Lett 21: 6646-51 (2011)


Article DOI: 10.1016/j.bmcl.2011.09.074
BindingDB Entry DOI: 10.7270/Q28W3DQK
More data for this
Ligand-Target Pair
Dipeptidyl peptidase VIII


(Homo sapiens (Human))
BDBM50356592
PNG
(CHEMBL1910116)
Show SMILES CNC(=O)CN1Cc2c(nc(C)c(CN)c2-c2ccc(Cl)cc2Cl)C1=O |(7.18,-19.79,;7.95,-21.12,;9.49,-21.12,;10.26,-22.45,;10.26,-19.78,;11.79,-19.78,;12.69,-21.03,;14.16,-20.55,;14.16,-19.01,;15.49,-18.24,;16.82,-19,;18.16,-18.23,;16.83,-20.55,;18.17,-21.32,;19.5,-20.55,;15.49,-21.32,;15.5,-22.86,;14.16,-23.63,;14.16,-25.17,;15.49,-25.94,;15.49,-27.48,;16.83,-25.16,;16.83,-23.62,;18.16,-22.85,;12.7,-18.54,;12.22,-17.07,)|
Show InChI InChI=1S/C18H18Cl2N4O2/c1-9-12(6-21)16(11-4-3-10(19)5-14(11)20)13-7-24(8-15(25)22-2)18(26)17(13)23-9/h3-5H,6-8,21H2,1-2H3,(H,22,25)
PDB

KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
2.24E+3n/an/an/an/an/an/an/an/a



Bristol-Myers Squibb Research and Development

Curated by ChEMBL


Assay Description
Inhibition of DPP8


Bioorg Med Chem Lett 21: 6646-51 (2011)


Article DOI: 10.1016/j.bmcl.2011.09.074
BindingDB Entry DOI: 10.7270/Q28W3DQK
More data for this
Ligand-Target Pair
Dipeptidyl peptidase 9


(Homo sapiens (Human))
BDBM50356592
PNG
(CHEMBL1910116)
Show SMILES CNC(=O)CN1Cc2c(nc(C)c(CN)c2-c2ccc(Cl)cc2Cl)C1=O |(7.18,-19.79,;7.95,-21.12,;9.49,-21.12,;10.26,-22.45,;10.26,-19.78,;11.79,-19.78,;12.69,-21.03,;14.16,-20.55,;14.16,-19.01,;15.49,-18.24,;16.82,-19,;18.16,-18.23,;16.83,-20.55,;18.17,-21.32,;19.5,-20.55,;15.49,-21.32,;15.5,-22.86,;14.16,-23.63,;14.16,-25.17,;15.49,-25.94,;15.49,-27.48,;16.83,-25.16,;16.83,-23.62,;18.16,-22.85,;12.7,-18.54,;12.22,-17.07,)|
Show InChI InChI=1S/C18H18Cl2N4O2/c1-9-12(6-21)16(11-4-3-10(19)5-14(11)20)13-7-24(8-15(25)22-2)18(26)17(13)23-9/h3-5H,6-8,21H2,1-2H3,(H,22,25)
PDB

KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
5.77E+3n/an/an/an/an/an/an/an/a



Bristol-Myers Squibb Research and Development

Curated by ChEMBL


Assay Description
Inhibition of DPP9


Bioorg Med Chem Lett 21: 6646-51 (2011)


Article DOI: 10.1016/j.bmcl.2011.09.074
BindingDB Entry DOI: 10.7270/Q28W3DQK
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))
BDBM50356592
PNG
(CHEMBL1910116)
Show SMILES CNC(=O)CN1Cc2c(nc(C)c(CN)c2-c2ccc(Cl)cc2Cl)C1=O |(7.18,-19.79,;7.95,-21.12,;9.49,-21.12,;10.26,-22.45,;10.26,-19.78,;11.79,-19.78,;12.69,-21.03,;14.16,-20.55,;14.16,-19.01,;15.49,-18.24,;16.82,-19,;18.16,-18.23,;16.83,-20.55,;18.17,-21.32,;19.5,-20.55,;15.49,-21.32,;15.5,-22.86,;14.16,-23.63,;14.16,-25.17,;15.49,-25.94,;15.49,-27.48,;16.83,-25.16,;16.83,-23.62,;18.16,-22.85,;12.7,-18.54,;12.22,-17.07,)|
Show InChI InChI=1S/C18H18Cl2N4O2/c1-9-12(6-21)16(11-4-3-10(19)5-14(11)20)13-7-24(8-15(25)22-2)18(26)17(13)23-9/h3-5H,6-8,21H2,1-2H3,(H,22,25)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a>1.70E+4n/an/an/an/an/an/a



Bristol-Myers Squibb Research and Development

Curated by ChEMBL


Assay Description
Inhibition of CYP3A4 up to 40 uM


Bioorg Med Chem Lett 21: 6646-51 (2011)


Article DOI: 10.1016/j.bmcl.2011.09.074
BindingDB Entry DOI: 10.7270/Q28W3DQK
More data for this
Ligand-Target Pair